425: Strive Acquires Semler Scientific, Boosts Bitcoin Treasury

Strive, Inc. announced the acquisition of Semler Scientific, Inc. in an all-stock transaction, aiming to rapidly expand its Bitcoin treasury and unlock value from Semler's medical device business.

Summary

• Strive completed its reverse merger into Asset Entities, becoming public on September 16, 2025.
• One week later, on September 23, 2025, Strive announced the acquisition of Semler Scientific, Inc. (SMLR) in an all-stock transaction, believed to be the fastest acquisition for a newly public U.S. company.
• The transaction is accretive in Bitcoin per share terms for Strive, despite a 210% premium on Semler's Fiat stock price.
• The combined entity is estimated to hold approximately 10,900 Bitcoin.
• The acquisition aims to achieve scale necessary to access larger institutional capital markets, with some requiring a $5-6 billion market capitalization.
• The deal substantially improves Strive's credit profile, increasing the Bitcoin collateralized coverage (BTC) rating for Semler's convertible bond from 5.7 to 12.3 (a 217% increase).
• The collateral interest coverage ratio for the combined entities (including potential perpetual preferred equity) would increase from 8 years to 48 years (a 619% increase).
• Strive intends to monetize Semler's historically profitable medical device business, which is currently undervalued by the market (perceived as zero or negative value), by expanding its mandate in preventative healthcare.
• Strive's strategy for Bitcoin acquisition prioritizes speed in a 'digital gold rush' era, deploying capital quickly based on a long-term view of Bitcoin's 30%+ Compound Annual Growth Rate (CAGR) versus an estimated 10% borrowing cost.
• The transaction timeline is expected to be a few months, primarily dependent on SEC timelines.
• Strive aims for 30-50% leverage using a perpetual preferred equity model, viewing it as a 'carry trade' to amplify Bitcoin exposure for common shareholders.
• There is a perceived significant opportunity for new credit rating agencies in the Bitcoin sphere due to traditional agencies' slow adoption and mispricing of Bitcoin-backed instruments.
• The current spread between AAA corporate bond yields (5.35%) and Strive's preferreds (around 10%) represents a substantial arbitrage opportunity.

Sentiment

Score: 9

Explanation: The filing details a highly strategic and accretive acquisition that significantly boosts Strive's Bitcoin holdings, enhances its credit profile, and accelerates its access to institutional capital. The management's clear framework for intelligent leverage and rapid Bitcoin accumulation, coupled with plans to monetize an undervalued operating business, indicates strong positive momentum and a well-defined strategy for long-term shareholder value creation.

Positives

• The acquisition is accretive in Bitcoin per share terms for Strive, aligning with its core objective.
• The combined entity will hold approximately 10,900 Bitcoin, significantly increasing its scale and market presence.
• Strive's credit profile is substantially improved, with Semler's convertible bond BTC rating increasing by 217% (from 5.7 to 12.3).
• The collateral interest coverage ratio for combined entities (including potential perpetual preferred equity) would increase by 619% (from 8 years to 48 years), enhancing financial stability.
• The deal unlocks access to larger institutional capital pools, such as those requiring a $5-6 billion market cap, facilitating future financing.
• It provides an opportunity to monetize Semler's undervalued, historically profitable medical device business, which focuses on preventative healthcare, adding a non-Bitcoin revenue stream.
• Strive's existing asset management business offers synergistic benefits, including in-house compliance and investor relations expertise, optimizing operational costs.
• The transaction demonstrates Strive's ability to operate at high speed in M&A, completing an acquisition one week after going public, showcasing strong execution capabilities.
• The perpetual preferred equity model offers a 'carry trade' opportunity, amplifying Bitcoin exposure for common shareholders by borrowing at 10% against an expected 30%+ Bitcoin CAGR.

Negatives

• The acquisition involved a 210% premium on Semler's Fiat stock price, which might be viewed negatively by some investors despite being accretive in Bitcoin terms.
• The market currently undervalues Semler's medical device business, perceiving it as having zero or negative value, requiring Strive to unlock this value.
• Traditional credit rating agencies are slow to adopt and appropriately rate Bitcoin-backed instruments, leading to a disconnect in perceived risk and limiting broader institutional adoption.
• The timeline for the transaction closing is dependent on SEC processes and could take a few months, introducing uncertainty.
• The market currently compresses MNAVs for Bitcoin Treasury companies with debt, potentially creating pressure on stock prices.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company.
• Unknown or unpredictable factors could also harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive anticipates that the acquisition of Semler Scientific will significantly accelerate its goal of accumulating a substantial Bitcoin war chest, enabling access to larger institutional capital markets. The combined entity aims to increase Bitcoin per share over time, driven by accretive M&A and intelligent leverage through perpetual preferred equity. Strive expects Bitcoin to appreciate at a 30%+ CAGR, making borrowing at 10% highly accretive. The company plans to monetize Semler's medical device business, potentially through an expanded mandate in preventative healthcare, to further accrete value. Strive also foresees innovation in Bitcoin-specific credit rating agencies to accurately assess the risk of Bitcoin-backed securities, which are currently undervalued by traditional markets.

Management Comments

• "The biggest winners in this space today, during this digital gold rush era, are going to be the ones that can acquire a war chest of Bitcoin in an accretive manner the fastest." Matt Cole
• "This was extremely accretive in Bitcoin per share terms for Strive, and I think on the long run basis, massively accretive for both sides." Matt Cole
• "One plus one equals 2.1 effectively, because you you have a bigger pool of capital that's now protecting two different components of what might be Bitcoin backed credit." Jeff Walton
• "The common equity is designed to, over the long run, behave like amplified Bitcoin, right outperform Bitcoin over the long run. Bitcoin is the hurdle rate for all capital decisions." Matt Cole
• "The idea is having Bitcoin backed, securitized credit instruments, right and right now, through the realm of perpetual preferred equity, which I think is the best one that you possibly could do, because you never have to repay the principal." Matt Cole
• "The excess risk and the excess return that that specific preferred equity holder is giving up is going to the common stock shareholder. That's effectively, we view this as a effectively a Bitcoin dividend reinvestment program." Jeff Walton
• "I would rather have a convertible note than no leverage." Matt Cole
• "There's not a bad a bad bond. It's only about prices." Matt Cole (quoting a mentor)
• "This is the biggest story in all of finance. I'm very certain of it. And there's just opportunity, boundless opportunity for for people everywhere." Jeff Walton

Industry Context

The acquisition highlights a growing trend among publicly traded companies to adopt a 'Bitcoin standard' and accumulate significant Bitcoin treasuries, following pioneers like MicroStrategy. Strive's rapid M&A strategy emphasizes speed in what it calls a 'digital gold rush era,' contrasting with companies that prioritize minimal dilution over rapid Bitcoin accumulation. The filing also points to the nascent but evolving market for Bitcoin-backed financial instruments, particularly perpetual preferred equity, which aims to attract institutional capital by offering amplified fixed income returns. The discussion on credit ratings underscores the challenge of traditional finance adapting to digital assets, creating an arbitrage opportunity for early movers and potentially fostering new, Bitcoin-native rating agencies. The focus on preventative healthcare for Semler's operating business also aligns with broader shifts in healthcare policy.

Comparison to Industry Standards

• Strive's strategy of rapidly acquiring Bitcoin through M&A, even with a 210% premium on Fiat stock price, contrasts with traditional corporate finance where such premiums are typically scrutinized for immediate EPS accretion in Fiat terms.
• The company's belief that Bitcoin will achieve a 30%+ CAGR over 5-10 years, allowing for accretive borrowing at 10%, sets a high hurdle rate for capital allocation decisions, a unique approach compared to traditional companies focused on WACC or ROIC.
• The significant improvement in credit metrics post-acquisition (e.g., 217% increase in BTC rating for Semler's convertible bond, 619% increase in collateral interest coverage ratio) suggests a stronger financial position than many standalone Bitcoin treasury companies or traditional firms with similar leverage.
• The discussion around perpetual preferred equity as a 'carry trade' to amplify Bitcoin exposure is an innovative financial engineering approach, distinct from standard corporate debt or equity issuance, and aims to outperform traditional fixed-income instruments.
• The observation that traditional credit rating agencies are slow to rate Bitcoin-backed instruments, potentially assigning 'junk' ratings despite internal analysis suggesting 'triple A' quality, highlights a significant market inefficiency and a disconnect from global financial benchmarks. This creates an arbitrage opportunity for investors willing to underwrite Bitcoin risk.
• The aspiration to become the 'MetaPlanet of the US' (a high-growth story with a clean balance sheet and intelligent leverage) indicates a benchmark against successful international Bitcoin treasury companies.

Management Changes

Corporate Governance

Legal Proceedings

• The filing mentions the possibility of legal proceedings being instituted against Strive or Semler Scientific or the combined company related to the proposed transaction.

Related Party Transactions

• Pierre Rochard, a speaker on The Bitcoin for Corporations Show, is an independent director on Strive's board of directors.

Stakeholder Impact

• Shareholders (Strive): Expected to benefit from increased Bitcoin per share, enhanced credit profile, access to larger institutional capital, and potential value unlock from Semler's medical device business.
• Shareholders (Semler Scientific): Expected to benefit from the 210% premium on Fiat stock price and the long-term value accretion from joining a larger, more liquid Bitcoin-focused entity with access to institutional capital.
• Employees (Semler Scientific): Potential for an 'expanded mandate' and 'fresh management team' for the medical device business, which could lead to new opportunities or restructuring.
• Customers (Semler Scientific): The medical device business, focused on preventative healthcare, may see an 'expanded mandate' and renewed investment, potentially improving offerings.
• Creditors (Semler Scientific): The credit profile of Semler's convertible bond is expected to substantially improve post-acquisition, reducing risk for existing creditors.
• Institutional Investors: The combined entity aims to reach a scale that unlocks access to larger institutional capital pools, creating new investment opportunities for them in Bitcoin-backed securities.

Next Steps

• Close the acquisition of Semler Scientific, which is expected to take a few months, dependent on SEC timelines.
• File a Registration Statement on Form S-4 with the SEC, including an Information Statement/Proxy Statement/Prospectus.
• Seek approval from Semler Scientific stockholders for the proposed transaction.
• Integrate the combined entities.
• Monetize Semler's medical device business, potentially with an expanded mandate around preventative healthcare.
• Launch a perpetual preferred equity instrument to access institutional capital and implement intelligent leverage.
• Explore ways to potentially retire Semler's convertible notes ahead of time.
• Continue to build the MSTR True North platform as an education node for the Bitcoin community.
• Potentially see the emergence of new, Bitcoin-focused credit rating agencies.

Key Dates

Recommendation

The acquisition of Semler Scientific by Strive is a highly strategic move that significantly enhances Strive's position as a Bitcoin Treasury company. The transaction is explicitly accretive in Bitcoin per share terms, which is the core objective for long-term value creation in this sector. The substantial increase in combined Bitcoin holdings (10,900 BTC) and the dramatic improvement in credit metrics (217% increase in BTC rating, 619% increase in interest coverage) de-risk the combined entity and open doors to larger institutional capital pools that were previously inaccessible. Furthermore, the plan to monetize Semler's undervalued medical device business provides an additional, non-Bitcoin-correlated value unlock. Management's clear framework for intelligent leverage through perpetual preferred equity, aiming to capitalize on Bitcoin's expected 30%+ CAGR against a 10% borrowing cost, demonstrates a sophisticated and aggressive strategy for amplifying shareholder returns. The speed of the acquisition post-reverse merger also highlights management's execution capability in a 'digital gold rush' environment. While there's a 210% Fiat premium, the focus on Bitcoin per share accretion and long-term strategic benefits justifies this from a Bitcoin-centric investment perspective. This filing signals strong growth potential and a well-executed strategy for outperforming Bitcoin over the long run.

Keywords

Bitcoin, Treasury, M&A, Acquisition, Reverse Merger, Semler Scientific, Strive, ASST, SMLR, Perpetual Preferred Equity, Convertible Bond, Medical Device, Preventative Healthcare, Institutional Capital, Credit Rating, Digital Gold Rush, Shareholder Value, Bitcoin per Share, Corporate Finance, SEC Filing